The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Oncolytics Biotech Inc up sharply

Oncolytics Biotech Inc closed up sharply Friday, rallying $0.03 or 5.26% to $0.60. Shares have lost 4.76% over the last five days, but have gained 55.84% over the last year to date. This security has underperformed the S&P TSX by 23.49% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated April 29 3:59 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4344
Selling / general / administrative0000
Research & development2223
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-4-3-4-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-3-3-4-4
Income after tax-3-3-4-4
Income tax, total0000
Net income-3-3-4-4
Total adjustments to net income--------
Net income before extra. items-3-3-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-3-4-4
Inc. avail. to common incl. extra. items-3-3-4-4
Diluted net income-3-3-4-4
Dilution adjustment0000
Diluted weighted average shares118118115100
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.02-0.03-0.04
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.03-0.02-0.03-0.04